Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women

Gynecologic Oncology

Volumn 117, Issue 2, 2010, Pages 287-290

  Zhou, Xiaoyi ^a   Chen, Xiaojun ^a,b   Hu, Lingmin ^a   Han, Suping ^a   Qiang, Fulin ^b   Wu, Yuling ^c   Pan, Li ^c   Shen, Hongbing ^a   Li, Ying ^c   Hu, Zhibin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Tumor Hospital of Nantong City   (China)

^c Jiangsu Research Centre for Reproductive Health in Humans   (China)

Author keywords

Cervical cancer; HPV; LAMB3; miR 218; Polymorphism

Indexed keywords

KALININ; KALININ BETA 3; MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; FEMALE; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 77950189124     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.01.020     Document Type: Article

References (25)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
3. Bosch F.X., Lorincz A., Muñoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55 (2002) 244-265
4. Roden R., and Wu T.C. How will HPV vaccines affect cervical cancer?. Nat. Rev. Cancer 6 (2006) 753-763
5. Zhang Y., Fan S., Meng Q., Ma Y., Katiyar P., Schlegel R., et al. BRCA1 interaction with human papillomavirus oncoproteins. J. Biol. Chem. 280 (2005) 33165-33177
6. Yim E.K., Lee K.H., Myeong J., Tong S.Y., Um S.J., and Park J.S. Novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1) and its biologic roles. DNA Cell Biol. 26 (2007) 753-761
7. Martinez I., Gardiner A.S., Board K.F., Monzon F.A., Edwards R.P., and Khan S.A. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27 (2008) 2575-2582
8. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
9. Zamore P.D., and Haley B. Ribo-gnome: the big world of small RNAs. Science 309 (2005) 1519-1524
10. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113 (2003) 673-676
11. Skyldberg B., Salo S., Eriksson E., Aspenblad U., Moberger B., Tryggvason K., et al. Laminin-5 as a marker of invasiveness in cervical lesions. J. Natl. Cancer Inst. 91 (1999) 1882-1887
12. Dajee M., Lazarov M., Zhang J.Y., Cai T., Green C.L., Russell A.J., et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421 (2003) 639-643
13. Calaluce R., Bearss D.J., Barrera J., Zhao Y., Han H., Beck S.K., et al. Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia 6 (2004) 468-479
14. Culp T.D., Budgeon L.R., Marinkovich M.P., Meneguzzi G., and Christensen N.D. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J. Virol. 80 (2006) 8940-8950
15. Mishra P.J., and Bertino J.R. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 10 (2009) 399-416
16. Hu Z., Liang J., Wang Z., Tian T., Zhou X., Chen J., et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 30 (2009) 79-84
17. Hu Z., Chen J., Tian T., Zhou X., Gu H., Xu L., et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 118 (2008) 2600-2608
18. Tian T., Shu Y., Chen J., Hu Z., Xu L., Jin G., et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol. Biomarkers Prev. 18 (2009) 1183-1187
19. Chen X., Han S., Wang S., Zhou X., Zhang M., Dong J., et al. Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin. Cancer Res. 15 (2009) 400-405
20. Xi Y., Shalgi R., Fodstad O., Pilpel Y., and Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin. Cancer Res. 12 (2006) 2014-2024
21. Zhou X., Han S., Wang S., Chen X., Dong J., Shi X., et al. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis. Gynecol. Oncol. 114 (2009) 327-331
22. Hoffman A.E., Zheng T., Yi C., Leaderer D., Weidhaas J., Slack F., et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 69 (2009) 5970-5977
23. Li L.K., Dai M., Clifford G.M., Yao W.Q., Arslan A., Li N., et al. Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br. J. Cancer 95 (2006) 1593-1597
24. Wu R.F., Dai M., Qiao Y.L., Clifford G.M., Liu Z.H., Arslan A., et al. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int. J. Cancer 121 (2007) 1306-1311
25. Dai M., Bao Y.P., Li N., Clifford G.M., Vaccarella S., Snijders P.J., et al. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br. J. Cancer 95 (2006) 96-101